On a mission to create the least invasive test to increase IVF pregnancy success. Starting with MIRA™, our less invasive miRNA-based endometrial receptivity status test that accurately predicts a patients Window of Implantation with a <1% fail rate.
Inti Labs was built on the shared vision of Dr. Barry Behr and Dr. Eric Pok Yang, long-time industry professionals representing two ends of the IVF process. Embryologist Dr. Behr sought a better way to evaluate and select eggs, while Dr. Yang focused on using microRNA (miRNA) to better predict each individual’s window of implantation (WOI).
Frustrated with the recent stagnation of IVF success rates, Dr. Behr and Dr. Yang came together over their mutual drive to reduce the burden on patients through less invasive, more impactful testing solutions.
Their vision: refining the IVF process to one day be able to reliably deliver a healthy baby using just a single egg, embryo, and implantation.
OUR MISSION
Today Inti Labs is dedicated to providing our clinical partners with tools that take each patient’s individual needs into account to enable more successful IVF outcomes. Further, we seek to empower patients and their families in making informed decisions early in their fertility journey.
